Ghost Tree Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-45,000
Closed -$7.57M 68
2018
Q1
$7.57M Sell
45,000
-750
-2% -$126K 1.53% 22
2017
Q4
$7.48M Buy
+45,750
New +$8.21M 1.76% 20
2015
Q4
Sell
-37,500
Closed -$10.2M 78
2015
Q3
$10.2M Sell
37,500
-7,500
-17% -$2.3M 4.59% 1
2015
Q2
$13.7M Buy
45,000
+10,000
+29% +$2.98M 4.43% 1
2015
Q1
$10.4M Buy
35,000
+17,500
+100% +$4.99M 3.75% 3
2014
Q4
$4.5M Buy
17,500
+2,500
+17% +$625K 2.16% 15
2014
Q3
$3.62M Sell
15,000
-15,000
-50% -$3.36M 1.96% 21
2014
Q2
$6.69M Buy
+30,000
New +$6.21M 4.72% 3

Other funds holding AGN

Ghost Tree Capital's AGN Position: Q2 2018 in Review

Ghost Tree Capital sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 45,000 shares — an estimated $7.57M sold.

Ghost Tree Capital first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $13.7M in Q2 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Ghost Tree Capital reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Ghost Tree Capital sold 45,000 Allergan plc shares in Q2 2018, an estimated $7.57M.
  • Ghost Tree Capital first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
  • Ghost Tree Capital's Allergan plc position peaked at $13.7M in Q2 2015.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Ghost Tree Capital's 13F filing for Q2 2018, filed 14 Aug 2018.